Interatrial Block, Bayés Syndrome, Left Atrial Enlargement, and Atrial Failure
Journal of Clinical Medicine · 26.11.2023 · 12 (23) · 7331
DOI: 10.3390/jcm12237331 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.11.2023. Verfasst von Roberto Bejarano-Arosemena und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Interatrial block (IAB) is defined by the presence of a P-wave ≥120 ms. Advanced IAB is diagnosed when there is also a biphasic morphology in inferior leads. The cause of IAB is complete block of Bachmann’s bundle, resulting in retrograde depolarization of the left atrium from areas near the atrioventricular junction. The anatomic substrate of advanced IAB is fibrotic atrial cardiomyopathy. Dyssynchrony induced by advanced IAB is frequently a trigger and maintenance mechanism of atrial fibrillation (AF) and other atrial arrhythmias. Bayés syndrome is characterized by the association of advanced IAB with atrial arrhythmias. This syndrome is associated with an increased risk of stroke, dementia, and mortality. Advanced IAB frequently produces an alteration of the atrial architecture. This atrial remodeling may promote blood stasis and hypercoagulability, triggering the thrombogenic cascade, even in patients without AF. In addition, atrial remodeling may ultimately lead to mechanical dyssynchrony and enlargement. Atrial enlargement is usually the result of prolonged elevation of atrial pressure due to various underlying conditions such as IAB, diastolic dysfunction, left ventricular hypertrophy, valvular heart disease, hypertension, and athlete’s heart. Left atrial enlargement (LAE) may be considered present if left atrial volume indexed to body surface is > 34 mL/m2; however, different cut-offs have been used. Finally, atrial failure is a global clinical entity that includes any atrial dysfunction that results in impaired cardiac performance, symptoms, and decreased quality of life or life expectancy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiology Department, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain.
- School of Health and Biomedical Sciences, Universidad Europea, 28670 Madrid, Spain.
- School of Medicine, Universidad Complutense, 28040 Madrid, Spain.
ORCID-Profile: Manuel Martínez-Sellés
Zitieren
APA
Bejarano-Arosemena, R., & Martínez-Sellés, M. (2023). Interatrial Block, Bayés Syndrome, Left Atrial Enlargement, and Atrial Failure. Journal of Clinical Medicine, 12(23), 7331. https://doi.org/10.3390/jcm12237331
Vancouver
Bejarano-Arosemena R, Martínez-Sellés M. Interatrial Block, Bayés Syndrome, Left Atrial Enlargement, and Atrial Failure. Journal of Clinical Medicine. 2023;12(23):7331. doi:10.3390/jcm12237331
BibTeX
@article{BejaranoArosemena2023,
author = {Bejarano-Arosemena, Roberto and Martínez-Sellés, Manuel},
title = {Interatrial Block, Bayés Syndrome, Left Atrial Enlargement, and Atrial Failure},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {23},
pages = {7331},
doi = {10.3390/jcm12237331}
}
EUVIMED